Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

Aug 5, 2011

30339_dirs_2011-08-05_6160e350-dc3b-4a0e-84e7-026583a5e291.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-08-01

Reporting Person: Malone Daniel (Vice President & Controller)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2567.3737 Direct
Common Stock 1808.5546 Indirect
Common Stock 2020.0793 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $32.0900 2019-02-24 Common Stock (2500.0000) Direct
Stock Option (Right to Buy) $34.4500 2016-06-22 Common Stock (2228.0000) Direct
Stock Option (Right to Buy) $40.8500 2021-02-22 Common Stock (4281.0000) Direct
Stock Option (Right to Buy) $41.7000 2018-02-26 Common Stock (2062.0000) Direct
Stock Option (Right to Buy) $42.6800 2020-03-22 Common Stock (4729.0000) Direct
Stock Option (Right to Buy) $44.9700 2017-02-27 Common Stock (1975.0000) Direct